Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
about
Analysis of duration of risk behaviour for key populations: a literature reviewHepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugsAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsSocial-level correlates of shooting gallery attendance: a focus on networks and norms.Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India.An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users.Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysisRisk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, IndiaHepatitis C transmission and treatment in contact networks of people who inject drugs.Guidance on the use of increased infectious risk donors for organ transplantation.Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.The role of living context in prescription opioid injection and the associated risk of hepatitis C infection.Limited infection with occult hepatitis B virus in drug users in the USA.Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groupsSeroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States-Mexico borderCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMeta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario.Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.Identifying heterogeneity among injection drug users: a cluster analysis approach.
P2860
Q27011344-26B29724-1FBC-42DA-B4C9-B76FE19E708BQ28484576-CB409758-FABC-4F98-8BCF-BE579287808FQ28548643-CF0A40E6-2A19-4804-AFBB-A22832024CA4Q30976942-B498F897-48D6-46B0-9BBF-8B124911C960Q33807767-5E489B01-6A14-444C-81D3-CA4B7520CE76Q33869403-50717C49-C53C-4D1D-AD9A-10C8E766C0B3Q34025691-91493027-F5AA-4A93-873D-B5344FF32E2FQ35032348-9FC2321C-D7E2-463C-BAC3-1D2E3C5785C4Q35032861-AB31DC36-42B6-440F-9B6E-AFE24C95233CQ35037944-49C1CD95-23B6-4ED8-AD4D-A701D25A22EFQ35040866-2814702E-3987-4354-A2D3-52F9DA2833CFQ35295449-981CF1D5-1376-4012-8CA5-510A109255E8Q35819898-67A0F864-3151-4ED2-8EA5-D4E346FEC954Q36033587-587B1C35-B7A5-4348-AC6D-E37A189D84A3Q36420099-81549A6D-EE9D-42B0-9C06-CD339C0E67FEQ36482820-6DFFCD5E-02E9-4384-B164-67A990CDF81DQ37031381-26D39755-D3F6-4653-B940-AA9CFE73FEB0Q37041349-1F427501-EE33-4AE0-87A6-CC7BD6FB02B5Q37100669-AA5CDF99-4265-4DEA-A290-9B180AD9483CQ37306146-6D99F8C2-06AB-49AD-8CDC-CECD4A22C787Q37499070-2764D31D-78F9-41C7-ADA4-ED811AC81166Q38255693-05FD02D7-0925-4C46-8230-8B2D77EFB611Q42197246-3538ED36-8C52-4367-AEF8-809EDA6F2FDDQ42988776-2BD3EAE6-1B42-42AB-B847-9F2B5F0732ECQ45324846-100A5364-C562-4E4D-AC3D-6337B3AC80DFQ48371623-1CAB1C79-1DAB-409F-96CF-3E1C7229E59DQ51698391-35BCF4D5-1AB4-4082-9F20-50C3E024ABB7
P2860
Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@ast
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@en
type
label
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@ast
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@en
prefLabel
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@ast
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@en
P2093
P2860
P356
P1433
P1476
Demographic, risk behaviour an ...... rug users in Winnipeg, Canada.
@en
P2093
Ann M Jolly
John L Wylie
P2860
P2888
P356
10.1186/1471-2458-6-229
P407
P577
2006-09-13T00:00:00Z
P5875
P6179
1043150627